Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle

Vaccine

Volumn 20, Issue 21-22, 2002, Pages 2693-2701

  Aspden, Kate ^a   Van Dijk, Alberdina A ^b,c   Bingham, John ^b,d   Cox, Dermot ^a   Passmore, Jo Ann ^a   Williamson, Anna Lise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^c CSIRO   (Australia)

^d Australian Animal Health Laboratory   (Australia)

Author keywords

Lumpy skin disease virus; Rabies; Rabies glycoprotein; Recombinant vaccine

Indexed keywords

BETA GALACTOSIDASE; GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; RABIES VACCINE; RECOMBINANT VACCINE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; LUMPY SKIN DISEASE VIRUS VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; CATTLE; CELLULAR IMMUNITY; CULTURE TECHNIQUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; POXVIRUS; REPORTER GENE; VACCINATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; CATTLE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES VIRUS; SERODIAGNOSIS;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; BETA-GALACTOSIDASE; CATTLE; CELL CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, REPORTER; GENETIC VECTORS; GLYCOPROTEINS; IMMUNITY, CELLULAR; LUMPY SKIN DISEASE VIRUS; RABIES VACCINES; VACCINATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; ANIMAL; CELL CULTURE; SUPPORT, NON-U.S. GOV'T;

EID: 0037150489     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00203-7     Document Type: Article

References (46)

1. Family rhabdoviridae
2. Structure of the glycoprotein gene of rabies virus
3. Rabies virus glycoprotein. Part II. Biological and serological characterization
4. Efficacy studies on a canarypox-rabies recombinant virus
5. Rhabdoviruses
6. Immunisation with canarypox virus expressing rabies glycoprotein
7. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep
8. Protective efficiency in mice of post exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein
9. Expression of Rabies virus glycoprotein from a recombinant Vaccinia virus
10. Potential use of non-replicating vectors as recombinant vaccines
11. Recombinant poxvirus vaccines
12. Genetically engineered poxviruses for recombinant gene expression, variation, and safety
13. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies a link between Jenner and Pasteur
14. Disseminated vaccinia in military recruit with human immunodeficiency virus (HIV) disease
15. Lumpy skin disease virus
16. Experimental infection of game animals with lumpy skin disease virus (prototype strain Neethling)
17. A single vaccine for the control of capripox infection in sheep and goats
18. Lumpy skin disease virus as a recombinant vaccine vector for rift valley fever virus and bovine ephemeral fever virus
19. Single capripox recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease
20. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: Protection of cattle against rinderpest and lumpy skin disease virus
21. Rabies
22. Rabies in southern Africa
23. Rabies in farm livestock in Nigeria
24. An outbreak of rabies in north-western Zimbabwe 1980-1983
25. The effects of war on the control of diseases of livestock in Rhodesia (Zimbabwe)
26. An outbreak of vampire bat-transmitted rabies in cattle in northeastern Mexico
27. Genetic characterization of rabies field isolates from Venezuela
28. Genetic characterization and geographic distribution of rabies virus isolates in Brazil: Identification of two reservoirs, dogs and vampire bats
29. Antibody response in cattle after vaccination woth inactivated and attenuated rabies vaccines
30. Epidemiological surveillance of rabies in Lithuania from 1986 to 1996
31. Measures applied in Denmark to control the rabies epizootic in 1977/1980
32. Clinical experiences with rabies in cattle in hungary
33. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes
34. The pMTL nic-cloning vectors. Part I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing
35. Use of E. coli lacZ (B-galactosidase) as a reporter gene
36. Manipulation of baculovirus vectors. Chapter 13
37. Development of F1 antibody virus neutralisation test (FAVN) for the quantitation of rabies virus neutralising antibodies
38. Rabies antibody titres in vaccines: Protection, failure and prospects
39. Evaluation of post-exposure vaccination against rabies in cattle
40. Protection of goats against peste des petits ruminants with recombinants capripoxviruses expressing the fusion and haemagglutinin protein genes of a rinderpest virus